FATTY LIVER
Clinical trials for FATTY LIVER explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER trials appear
Sign up with your email to follow new studies for FATTY LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin B3 trial aims to halt liver damage
Disease control Recruiting nowThis study is testing whether a form of vitamin B3 called nicotinamide can stop or even reverse liver scarring (fibrosis) in people with fatty liver disease. About 30 overweight or obese adults will take either nicotinamide or a placebo pill daily for one year. Researchers will u…
Matched conditions: FATTY LIVER
Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Can eating on a schedule fix a fatty liver without weight loss?
Disease control Recruiting nowThis study is testing if time-restricted eating (a form of intermittent fasting) can reduce fat in the liver for adults who have non-alcoholic fatty liver disease (NAFLD) but are not obese. Researchers want to see if this lifestyle change, independent of major weight loss, can be…
Matched conditions: FATTY LIVER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Common mucus drug tested as new hope for fatty liver
Disease control Recruiting nowThis study is testing whether a medication called erdosteine, often used for mucus in lung conditions, can help treat nonalcoholic fatty liver disease (NAFLD). It will involve 50 adult patients with NAFLD to see if the drug safely reduces fat buildup and scarring in the liver. Th…
Matched conditions: FATTY LIVER
Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Common heart drug may hold key to fighting silent liver epidemic
Disease control Recruiting nowThis study is testing whether a drug called cilostazol, already used for other conditions, can help treat nonalcoholic fatty liver disease (NAFLD). It will involve 50 adult patients with NAFLD to see if the drug safely reduces the amount of fat and scarring in their livers. The m…
Matched conditions: FATTY LIVER
Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Scientists launch 18-Year quest to unlock secrets of childhood obesity
Knowledge-focused Recruiting nowThis study aims to understand how a mother's health, weight, and blood sugar during pregnancy affect her child's growth and risk for obesity, diabetes, and fatty liver disease later in life. Researchers will follow 1,500 Hispanic and American Indian/Alaska Native mothers and thei…
Matched conditions: FATTY LIVER
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC